CLN-978: The Future of Lupus, Rheumatoid Arthritis, and Sjögren’s Disease Treatment
Автор: CreakyJoints
Загружено: 2025-10-22
Просмотров: 21328
Описание:
Autoimmune conditions like lupus, rheumatoid arthritis, and Sjögren’s disease affect millions of people around the world. Even with available treatments, many patients continue to face persistent symptoms and long-term challenges.
In this video, Dr. Jeff Jones, Chief Medical Officer at Cullinan Therapeutics, introduces CLN-978, a therapy with the potential to change how we treat autoimmune conditions like lupus, rheumatoid arthritis, and Sjögren’s disease.
This investigational therapy is called a T cell engager and is designed to precisely target and remove abnormal B cells that drive autoimmune activity. By resetting the immune system rather than broadly suppressing it, CLN-978 has the potential to transform how autoimmune diseases are treated.
You’ll learn:
• What CLN-978 is and how it works
• How it differs from existing therapies, including CAR-T treatments
• How CLN-978 is designed to be an “off-the-shelf” therapy delivered through a simple subcutaneous (under-the-skin) injection
A new investigational therapy.
A step forward in autoimmune research.
To learn more about CLN-978, visit: https://linktr.ee/cln978
This program was made possible with support from Cullinan Therapeutics.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
